Clinicians (n = 43) | Parents (n = 23) | |||||
---|---|---|---|---|---|---|
Outcome | Clinician rank | Median (IQR) | Number (%) scoring outcome in top 3 | Parent rank | Median (IQR) | Number (%) scoring outcome in top 3 |
Nocturnal symptoms | 1 | 4 (3, 4) | 19 (44) | 1= | 4 (4, 4) | 10 (43) |
Exacerbations | 2 | 4 (3, 4) | 15 (35) | 3 | 4 (4, 4) | 7 (30) |
Quality of life | 3 | 3 (3, 4) | 13 (30) | 4 | 4 (3, 4) | 5 (22) |
Daytime symptoms | 4 | 4 (3, 4) | 11 (26) | 10 | 4 (3, 4) | 3 (13) |
Death | 5 | 4 (2, 4) | 10 (23) | 1= | 4 (4, 4) | 10 (43) |
Hospital admission | 6 | 4 (3, 4) | 9 (21) | 7 | 4 (4, 4) | 4 (17) |
Parent/child global assessment of control | 7 | 4 (3, 4) | 9 (21) | 11 | 4 (3, 4) | 3 (13) |
Impact of asthma on the family | 8 | 4 (3, 4) | 8 (19) | 16 | 4 (3, 4) | 1 (4) |
Use of reliever | 9 | 3 (3, 4) | 8 (19) | 8 | 4 (3, 4) | 4 (17) |
Normal activities | 10 | 4 (3, 4) | 5 (12) | 14 | 4 (3, 4) | 2 (9) |
Long-term AE | 11 | 4 (3, 4) | 7 (16) | 13 | 4 (4, 4) | 2 (9) |
School attendance | 12 | 3 (3, 4) | 5 (12) | 6 | 4 (3, 4) | 5 (22) |
Activity or exercise | 13 | 3 (3, 4) | 4 (9) | 12 | 3 (2, 4) | 3 (13) |
GP/A + E attendance | 14 | 4 (3, 4) | 4 (9) | 15 | 4 (3, 4) | 2 (9) |
Growth | 15 | 3 (3, 4) | 3 (7) | 9 | 4 (3, 4) | 3 (13) |
Health-related problems when older | 16 | 3 (2, 4) | 0 | 5 | 4 (4, 4) | 5 (22) |
Short-term AE | 17 | 3 (2, 3) | 0 | 17 | 3 (3, 4) | 0 |